(Q35176153)

6 August 2017

1 reference

title

The use of aspirin in ischemic heart disease (English)

1 reference

6 August 2017

The Use of Aspirin in Ischemic Heart Disease (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

23 November 2023

1 reference

coronary artery disease

1 reference

J. E. Willard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285747

9 September 2022

R. A. Lange

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285747

9 September 2022

L. D. Hillis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285747

9 September 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

6 August 2017

16 July 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1285747

full work available at URL

9 September 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199207163270308

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

The New England Journal of Medicine

23 November 2023

published in

1 reference

6 August 2017

327

1 reference

6 August 2017

3

1 reference

6 August 2017

175-181

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin selectively inhibits prostaglandin production in human platelets

23 November 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

23 November 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction

23 November 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

23 November 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects

23 November 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

23 November 2023

Federation Proceedings

10

38

66

Moncada

1979

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin

23 November 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin

23 November 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

23 November 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes

23 November 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

23 November 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Coronary artery thrombosis in patients with unstable angina

23 November 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Angiographic morphology and the pathogenesis of unstable angina pectoris

23 November 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris

23 November 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Coronary angioscopy in patients with unstable angina pectoris

23 November 2023

20

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

23 November 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

23 November 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Platelet activation in unstable coronary disease

23 November 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Fibrinopeptide A and platelet factor levels in unstable angina pectoris

23 November 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease

23 November 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries

23 November 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries

23 November 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries

23 November 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

23 November 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo

23 November 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

23 November 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina

23 November 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

23 November 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

23 November 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin, heparin, or both to treat acute unstable angina

23 November 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

The pathogenesis of atherosclerosis--an update

23 November 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet

23 November 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Final report on the aspirin component of the ongoing Physicians' Health Study

23 November 2023

40

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians

23 November 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Circadian variation in the frequency of onset of acute myocardial infarction

23 November 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

23 November 2023

43

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Morning increase in platelet aggregability. Association with assumption of the upright posture

23 November 2023

44

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians

23 November 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

A prospective study of aspirin use and primary prevention of cardiovascular disease in women

23 November 2023

47

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

23 November 2023

48

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

23 November 2023

53

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

23 November 2023

54

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

23 November 2023

58

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

23 November 2023

59

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Acute effects of transluminal angioplasty in three experimental models of atherosclerosis

23 November 2023

61

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Morphology after transluminal angioplasty in human beings

23 November 2023

62

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model

23 November 2023

63

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

23 November 2023

64

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

23 November 2023

65

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

23 November 2023

66

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

23 November 2023

67

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Restenosis after successful coronary angioplasty. Pathophysiology and prevention

23 November 2023

68

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Changes in saphenous veins used as aortocoronary bypass grafts

23 November 2023

70

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study

23 November 2023

71

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts

23 November 2023

74

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

23 November 2023

75

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery

23 November 2023

76

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation

23 November 2023

77

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

23 November 2023

79

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations

23 November 2023

80

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study

23 November 2023

81

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Platelets and antiplatelet therapy in ischemic heart disease

23 November 2023

82

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

23 November 2023

Dipyridamole

83

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

Journal of the American College of Cardiology

23 November 2023

84

13

238A

Violi

1989

1 reference

https://api.crossref.org/works/10.1056/NEJM199207163270308

23 November 2023

Identifiers

1 reference

6 August 2017

1 reference